XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value of Financial Instruments
3 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

The Company’s financial instruments generally include cash and cash equivalents, short-term investments, trade accounts, financing receivables and accounts payable. Due to the short-term maturities of cash and cash equivalents, trade accounts and financing receivables and accounts payable, the carrying amounts of these financial instruments are deemed to approximate their fair value on the respective balance sheet dates. The valuation technique used to measure the fair value of the contingent consideration was based on internal estimates and the use of internal projections of future revenue.

The Company measures its short-term investments and contingent consideration at fair value on a recurring basis.

The following tables present the fair value of the Company’s short-term investments and contingent consideration by valuation hierarchy and input (in thousands):

 

 

 

As of December 31, 2021

 

 

 

Quoted Prices in
Active Markets for
Identical Assets
 (Level 1)

 

 

Significant
Other
Observable
(Level 2)

 

 

Significant
Unobservable
(Level 3)

 

 

Totals

 

 Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

     Corporate bonds

 

$

 

 

$

7,625

 

 

$

 

 

$

7,625

 

Total assets

 

$

 

 

$

7,625

 

 

$

 

 

$

7,625

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Current portion

 

 

 

 

 

 

 

 

(247

)

 

 

(247

)

Non-current portion

 

 

 

 

 

 

 

 

(2,523

)

 

 

(2,523

)

Total liabilities

 

$

 

 

$

 

 

$

(2,770

)

 

$

(2,770

)

 

 

 

As of September 30, 2021

 

 

 

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
(Level 2)

 

 

Significant
Unobservable
(Level 3)

 

 

Totals

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

       Corporate bonds

 

$

 

 

$

9,496

 

 

$

 

 

$

9,496

 

       Total assets

 

$

 

 

$

9,496

 

 

$

 

 

$

9,496

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liabilities

 

$

 

 

$

 

 

$

(6,017

)

 

$

(6,017

)

Total liabilities

 

$

 

 

$

 

 

$

(6,017

)

 

$

(6,017

)

The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the three months ended December 31, 2021 and 2020

 

Balance at October 1, 2021

$

6,017

 

Fair value adjustments

 

(2,440

)

Payment of contingent consideration

 

(807

)

Balance at December 31, 2021

$

2,770

 

 

 

 

Balance at October 1, 2020

$

10,962

 

Fair value adjustments

 

(697

)

Payment of contingent consideration

 

 

Balance at December 31, 2020

$

10,265

 

 

 

Adjustments to the fair value of the contingent consideration are based on internal estimates and management assessments regarding potential future scenarios. The Company believes its estimates and assumptions are reasonable, however, there is significant judgment involved. Also see Note 11.